Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TriLink Biotechnologies

https://www.trilinkbiotech.com/

Latest From TriLink Biotechnologies

OliX Diversifies Into mRNA Amid Growing Global Interest

Amid the highly successful launch of COVID-19 vaccines using the technology by Pfizer/BioNTech and Moderna, South Korean bioventure OliX Pharmaceuticals is diversifying into the mRNA field by establishing a new subsidiary that focuses on R&D into new vaccines and therapeutics using the platform.

South Korea Research and Development Strategies
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Services
  • Contract Manufacturing Organization
  • Biotechnology
    • Antisense, Oligonucleotides
    • Synthesis Technologies, Production Processes
    • Drug Discovery Tools
      • Genomics-Proteomics
UsernamePublicRestriction

Register